Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-060908

Chief Science & Business Off bought 670 shares at an average $15.33 ($10,273)

From the SEC's structured data for this filing

Trades in this filing

Poradosu Enrique · Chief Science & Business Off

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-12 Purchase : show line 1 in the form +370 $14.76 $5,461 1,258,019 D
2022-05-12 Purchase : show line 2 in the form +300 $16.04 $4,812 1,258,319 D
Open-market purchases · 670 sh · avg $15.33 · $10,273
Loading xslF345X03/tm2215423-1_4seq1.xml…